Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radioprotective gene therapy.

J S Greenberger1, M W Epperly, J Gretton

  • 1Department of Radiation Oncology, University of Pittsburgh Cancer Institute, Department of Environmental Health Science, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15213, USA. greenbergerjs@msx.upmc.edu

Current Gene Therapy
|May 24, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Clinical features and fistula acoustic characteristics in maintenance hemodialysis patients with versus without diabetes mellitus].

Zhonghua yi xue za zhi·2026
Same author

[Analysis of influencing factors and construction of a prediction model for high-risk colorectal adenomas].

Zhonghua yi xue za zhi·2026
Same author

[A case of infant Danon disease presenting with myocardial hypertrophy as the initial manifestation].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2026
Same author

[Real world clinical data analysis of fuzuloparib for the treatment of ovarian epithelial cancer patients].

Zhonghua fu chan ke za zhi·2025
Same author

[The study on horizontal sound localization ability in patients with unilateral sensorineural hearing loss].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2025
Same author

[Horizontal sound localization in young and middle-aged patients with symmetric sensorineural hearing loss in noisy environments].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2025
Same journal

Identifying Basement Membrane-Related Diagnostic Biomarkers for Rheumatoid Arthritis Through Machine Learning.

Current gene therapy·2026
Same journal

A Multi-Gene Myofibroblast Framework Stratifies Prognostic and Immune Landscapes in HCC.

Current gene therapy·2026
Same journal

Single-cell Transcriptomics Inference of Neutrophil-mast Cell Communication Programs in Periodontitis.

Current gene therapy·2026
Same journal

GULP1 in Ovarian Cancer: Expression, Biological Function, and Clinical Significance.

Current gene therapy·2026
Same journal

Single‑cell Transcriptomic Profiling of Bone Marrow Mesenchymal Stem Cells Reveals Lineage Heterogeneity and Dysregulated Osteoblast Genes in Osteoporosis Versus Osteoarthritis.

Current gene therapy·2026
Same journal

Surface Functionalization of 3D-Printed Porous Ti-6Al-4V Scaffolds with PDA‑mHA-Col I Composite Coating Drives Macrophage Polarization toward the M2 Phenotype and Promotes Immunomodulation: An In Vitro Study.

Current gene therapy·2026
See all related articles

Radioprotective gene therapy using manganese superoxide dismutase (MnSOD) protects organs from radiation damage. This approach shows promise in reducing toxicity and potentially increasing cancer radiotherapy doses.

Area of Science:

  • Oncology
  • Gene Therapy
  • Radiation Biology

Background:

  • Cancer radiotherapy is often limited by organ-specific toxicity to normal tissues.
  • Irradiation-induced damage manifests as acute effects and chronic fibrosis, leading to organ failure.
  • Existing treatments lack sufficient radioprotection, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To develop and evaluate radioprotective gene therapy using manganese superoxide dismutase (MnSOD).
  • To investigate the efficacy of MnSOD gene therapy in preventing organ-specific radiation toxicity.
  • To assess the potential of MnSOD gene therapy to improve cancer radiotherapy outcomes.

Main Methods:

  • Developed gene therapy vectors (plasmid/liposomes and adenovirus) for MnSOD delivery to target organs.

Related Experiment Videos

  • Utilized MnSOD transgene constructs, with and without mitochondrial localization signals, to study protection mechanisms.
  • Administered MnSOD-plasmid/liposomes (MnSOD-PL) via organ-specific injection prior to irradiation in rodent models.

    • Main Results:

    • MnSOD transgene overexpression localized to mitochondria proved critical for radioprotection.
    • Organ-specific MnSOD-PL injection led to transgene expression and reduced inflammatory cytokine response.
    • Significant reduction in organ-specific tissue injury was observed in preclinical models.

    Conclusions:

    • Radioprotective gene therapy with MnSOD effectively mitigates ionizing irradiation-induced organ damage.
    • Clinical trials are underway for preventing esophagitis and mucositis in cancer patients.
    • MnSOD gene therapy may enable higher radiotherapy doses, improving the therapeutic ratio in cancer treatment.